Repeats [Study As­sess­ment]

posted by sam – India, 2013-07-27 13:57 (4722 d 10:33 ago) – Posting: # 11071
Views: 25,515

Dear ElMaestro,

Thanks for the final conclusions.

If I am not wrong than we have to reformulate the formulation and try to get the ratio above 90% so that the formulation can qualify for the BE criteria.
Here I think we should not go for repeat of the whole study to waste of time and money.
One last suggestions I need from your end, if we go to repeat the whole study without any solid reason except the unexpected PE compared to the pilot study. What will be regulatory queries consequence with the regulatory approval. Will they approve our products based on the new data if it qualifies after repeat.


Regards

Sam

Complete thread:

UA Flag
Activity
 Admin contact
23,656 posts in 4,994 threads, 1,570 registered users;
272 visitors (0 registered, 272 guests [including 49 identified bots]).
Forum time: 00:30 CEST (Europe/Vienna)

Try to learn something about everything
and everything about something.    Thomas Henry Huxley

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5